Back to Search
RICHARD MIRELES, MDIU LPC
MDIU LPC
Professional Counselor
NPI: 1043251028Individual
Specialties, Licenses & Credentials
Research & Publications (7)
N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a "chemical knock-out equivalent" to assess the impact of efflux transporters on oral drug absorption in the rat.
PMID 19373887·J Pharm Sci·2009
7-preclinical
Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
PMID 19223659·Toxicol Sci·2009
8-other
In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
PMID 17962372·Drug Metab Dispos·2008
7-preclinical
Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
PMID 17686907·Drug Metab Dispos·2007
7-preclinical
Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.
PMID 16410371·Toxicol Sci·2006
7-preclinical
Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034.
PMID 16356485·Chem Biol Interact·2006
2-rct
Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.
PMID 15616150·Drug Metab Dispos·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5717 N 10TH, STE C
MCALLEN, TX 78504 - Phone
- (956) 686-6300
Quick Facts
- NPI
- 1043251028
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile